Connect
MJA
MJA

Statistics, epidemiology and research design

Letters

Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic

Rochelle Wynne, Caleb Ferguson and Patricia M Davidson

Med J Aust 2021; 215 (10): 485-485 Free

Editorials

On entering Australia’s third year with COVID‐19

Stephen J Duckett and Brett Sutton

Med J Aust 2021; 215 (11): 509-510 Free

Editorials

Measurement is the key to delivering culturally responsive care

Margaret P Kay

Med J Aust 2021; 215 (9): 412-413

Letters

Evidence and advocacy in Melbourne maternity care during the COVID‐19 pandemic

Lisa Hui, Clare Whitehead and Susan P Walker

Med J Aust 2021; 215 (9): 433-434 Free

Perspectives

The 2021 report of the MJA–Lancet Countdown on health and climate change: Australia increasingly out on a limb

Paul J Beggs, Ying Zhang, Alice McGushin, Stefan Trueck, Martina K Linnenluecke, Hilary Bambrick, Helen L Berry, Ollie Jay, Lucie Rychetnik, Ivan C Hanigan, Geoffrey G Morgan, Yuming Guo, Arunima Malik, Mark Stevenson, Donna Green, Fay H Johnston, Celia McMichael, Ian Hamilton and Anthony G Capon

Med J Aust 2021; 215 (9): 390-392.e22 Free

Research

The impact of re‐opening the international border on COVID‐19 hospitalisations in Australia: a modelling study

Mark J Hanly, Timothy Churches, Oisin Fitzgerald, Jeffrey J Post, C Raina MacIntyre and Louisa Jorm

Med J Aust 2022; 216 (1): 39-42 Free

Editorials

Eliminating hepatitis C in Australia needs informed patients and enabled GPs

Paul J Clark

Med J Aust 2021; 215 (7): 318-319

Letters

Selection criteria for Australian and New Zealand medical specialist training programs: another under‐recognised driver of research waste

Caitlyn Withers, Christy Noble, Caitlin Brandenburg, Paul P Glasziou and Paulina Stehlik

Med J Aust 2021; 215 (7): 336-336.e1

Research

Modelling direct and herd protection effects of vaccination against the SARS‐CoV‐2 Delta variant in Australia

Emma S McBryde, Michael T Meehan, Jamie M Caldwell, Adeshina I Adekunle, Samson T Ogunlade, MD Abdul Kuddus, Romain Ragonnet, Pavithra Jayasundara, James M Trauer and Robert C Cope

Med J Aust 2021; 215 (9): 427-432 Free

Research

The influence of the surveillance time interval on the risk of advanced neoplasia after non‐advanced adenoma removal

Zaki Hamarneh, Charles Cock, Graeme P Young, Peter A Bampton, Robert Fraser, Fang LI Ang, Feruza Kholmurodova and Erin L Symonds

Med J Aust 2021; 215 (10): 465-470 Free

Research letters

Background rates of hospital transfer and death in Australian aged care facilities: estimates to assist interpretation of rates after COVID‐19 vaccination

Hazel J Clothier, Yonatan M Mesfin, Steven Strange and Jim P Buttery

Med J Aust 2021; 215 (4): 180-181 Free

Letters

Why proper understanding of confidence intervals and statistical significance is important

James C Hurley

Med J Aust 2021; 215 (4): 190-190.e1

Letters

Why proper understanding of confidence intervals and statistical significance is important

Chris G Dalton

Med J Aust 2021; 215 (4): 191-191.e1

Editorials

The expanding geographic range of dengue in Australia

Annelies Wilder‐Smith

Med J Aust 2021; 215 (4): 171-172

Perspectives

Investigating the health impacts of the Ranger uranium mine on Aboriginal people

Rosalie Schultz

Med J Aust 2021; 215 (4): 157-159.e1 Free

Perspectives

The landscape of COVID‐19 trials in Australia

Anna Lene Seidler, Mason Aberoumand, Jonathan G Williams, Aidan Tan, Kylie E Hunter and Angela Webster

Med J Aust 2021; 215 (2): 58-61.e1 Free

Letters

The probability of the 6‐week lockdown in Victoria (commencing 9 July 2020) achieving elimination of community transmission of SARS‐CoV‐2

Bradley R Crammond and Vishaal Kishore

Med J Aust 2021; 215 (2): 95-95.e1 Free

Letters

The probability of the 6‐week lockdown in Victoria (commencing 9 July 2020) achieving elimination of community transmission of SARS‐CoV‐2

Jason Thompson, Natalie Carvalho and Tony Blakely

Med J Aust 2021; 215 (2): 96-96.e1 Free

Perspectives

Australia needs a prioritised national research strategy for clinical trials in a pandemic: lessons learned from COVID‐19

Asha C Bowen, Steven YC Tong and Joshua S Davis

Med J Aust 2021; 215 (2): 56-58.e1 Free

Research letters

Re‐defining the dengue‐receptive area of Queensland after the 2019 dengue outbreak in Rockhampton

Jacina Walker, Alyssa Pyke, Paul Florian, Rachael M Rodney Harris and Gulam Khandaker

Med J Aust 2021; 215 (4): 182-182 Free

Perspectives

Communicating with patients and the public about COVID‐19 vaccine safety: recommendations from the Collaboration on Social Science and Immunisation

Julie Leask, Samantha J Carlson, Katie Attwell, Katrina K Clark, Jessica Kaufman, Catherine Hughes, Jane Frawley, Patrick Cashman, Holly Seal, Kerrie Wiley, Katarzyna Bolsewicz, Maryke Steffens and Margie H Danchin

Med J Aust 2021; 215 (1): 9-12.e1 Free

Editorials

An update on the burden of group A streptococcal diseases in Australia and vaccine development

Jeffrey W Cannon and Asha C Bowen

Med J Aust 2021; 215 (1): 27-28

Research

Increasing incidence of invasive group A streptococcal disease in Western Australia, particularly among Indigenous people

Cameron M Wright, Rachael Moorin, Glenn Pearson, John R Dyer, Jonathan R Carapetis and Laurens Manning

Med J Aust 2021; 215 (1): 36-41 Free

Perspectives

Australia must act to prevent airborne transmission of SARS‐CoV‐2

Zoë Hyde, David Berger and Andrew Miller

Med J Aust 2021; 215 (1): 7-9.e1 Free

Perspectives

Surveillance for SARS‐CoV‐2 variants of concern in the Australian context

Patiyan Andersson, Norelle L Sherry and Benjamin P Howden

Med J Aust 2021; 214 (11): 500-502.e1 Free